CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-08 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise | +194 | $8.22 | $2K | 194 |
| 2024-03-08 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | −194 | $32.00 | $6K | 0 |
| 2024-03-08 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option | −100 | 2,335 | ||
| 2024-03-08 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option | −94 | 14,513 | ||
| 2024-01-24 | Budur Kumar CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +42,500 | 42,500 | ||
| 2024-01-24 | Budur Kumar CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +8,750 | 8,750 | ||
| 2024-01-24 | Dayno Jeffrey M. PRESIDENT, CEO | Grant or award · Stock Option | +202,250 | 202,250 | ||
| 2024-01-24 | Dayno Jeffrey M. PRESIDENT, CEO | Grant or award · Restricted Stock Units | +42,000 | 42,000 | ||
| 2024-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option | +52,500 | 52,500 | ||
| 2024-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +10,750 | 10,750 | ||
| 2024-01-24 | Serafin Andrew CHIEF STRATEGY OFFICER | Grant or award · Stock Option | +47,750 | 47,750 | ||
| 2024-01-24 | Serafin Andrew CHIEF STRATEGY OFFICER | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2024-01-24 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Grant or award · Stock Option | +74,250 | 74,250 | ||
| 2024-01-24 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +15,250 | 15,250 | ||
| 2023-11-05 | Anastasiou Peter Director | Grant or award · Stock Option | +6,771 | 6,771 | ||
| 2023-10-04 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2023-10-04 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2023-05-26 | Dayno Jeffrey M. PRESIDENT, CEO | Grant or award · Stock Option | +125,000 | 125,000 | ||
| 2023-05-26 | Dayno Jeffrey M. PRESIDENT, CEO | Grant or award · Stock Option | +125,000 | 125,000 | ||
| 2023-05-25 | Nielsen Jack Director | Grant or award · Stock Option | +5,224 | 26,224 |
Page 11 of 14 · 268 trades